Du är här


INC RESEARCH, LLC: INC Research Debuts New Interactive Website

Global CRO develops innovative features and engaging new content to better
connect with drug development communities

Raleigh, N.C., May 28, 2014
- INC Research, a leading global Phase I to IV clinical research organization
(CRO), today announced the launch of an all-new website (www.incresearch.com)
to deliver an interactive digital experience for stakeholders across the
clinical development process. Featuring a modern design, streamlined
architecture and innovative features allowing users to navigate and filter
content in a whole new way, the site provides pharmaceutical and biotech
companies, clinical research sites and other key stakeholders improved access
to information through a more interactive environment. A key feature of the
new website is dedicated therapeutic environments mirroring the Company's
therapeutic focus and alignment of its clinical teams to respond to customer
needs in the fastest-growing areas of clinical development.

"We're excited to launch a website that is uniquely different from anything
else we've seen in the industry," said Neil Ferguson, Executive Vice
President, Global Business Development, INC Research. "With an interactive
design and the functionality to filter and customize content in a simple and
intuitive way, we will provide a more engaging experience that better
connects users to the information and resources they need and brings our 'I
am INC Research' brand to life."

In addition to offering dedicated content for a wide variety of therapeutic
areas, the redesigned site features a user-friendly interface that makes it
easier for visitors to navigate and access the information most relevant to
them. The site also has been mobile-optimized so users can connect to
information and updates from their tablets or smartphones anywhere, anytime.

To experience the new INC Research website, please visitwww.incresearch.com.

About INC Research

INC Research is a leading, global full-service clinical research organization
(CRO) providing the full range ofPhase I to IV clinical development
servicesfor the world's pharmaceutical, biotech and medical device
industries. As a therapeutically focused CRO, with aTrusted Process®delivery
methodology, developing the medicines people need is something we take
personally. Leveraging the breadth of our service offerings and the depth of
ourtherapeutic expertiseacross multiple patient populations,INC Research
connectscustomers, investigative sites and patients to accelerate the
delivery of new medicines to market to improve world health. We were ranked
"Top CRO to Work With" by sites worldwide in the 2013 CenterWatch Global
Investigative Site Relationship Survey. INC Research is headquartered in
Raleigh, NC, with operations across six continents and experience spanning
more than 100 countries. For more information, please
visitwww.incresearch.comand connect with us onLinkedInand

Lori Dorer, Media +1 (513) 345-1685


This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: INC RESEARCH, LLC via Globenewswire


Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.